Industry NewsJapan warns over Mounjaro use for rapid weight loss
Japanese specialists warn against combining weight-loss injections with severe food restriction, as authorities highlight risks from unapproved use and informal sales.
Industry News
Novo Nordisk, Eli Lilly, the NHS, regulators and the business of GLP-1 drugs: supply, pricing, trials and policy.
Industry News
Industry NewsASA targets weight-loss drug adverts as Lilly faces complaints
Five pharmacy rulings clarify restrictions on promoting prescription weight-loss medicines, while complaints about Eli Lilly’s television campaign remain separate.